TC
REGN icon

TownSquare Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

TownSquare Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,345
Closed -$756K – 338
2025
Q3 		$756K Sell
1,345
-966
-42% -$546K 0.11% 165
2025
Q2 		$1.21M Sell
2,311
-7,753
-77% -$4.33M 0.12% 166
2025
Q1 		$6.38M Buy
10,064
+2,854
+40% +$1.96M 0.07% 271
2024
Q4 		$5.14M Buy
7,210
+379
+6% +$318K 0.06% 303
2024
Q3 		$7.18M Buy
6,831
+1,430
+26% +$1.59M 0.09% 231
2024
Q2 		$5.68M Buy
5,401
+609
+13% +$590K 0.08% 242
2024
Q1 		$4.61M Buy
4,792
+259
+6% +$246K 0.07% 275
2023
Q4 		$3.98M Sell
4,533
-2,169
-32% -$1.79M 0.07% 272
2023
Q3 		$5.52M Buy
6,702
+344
+5% +$270K 0.1% 191
2023
Q2 		$4.57M Buy
6,358
+1,983
+45% +$1.53M 0.08% 221
2023
Q1 		$3.59M Buy
4,375
+187
+4% +$141K 0.08% 225
2022
Q4 		$3.02M Buy
4,188
+313
+8% +$231K 0.07% 234
2022
Q3 		$2.67M Buy
3,875
+264
+7% +$166K 0.08% 221
2022
Q2 		$2.13M Buy
3,611
+218
+6% +$142K 0.06% 256
2022
Q1 		$2.37M Buy
3,393
+419
+14% +$265K 0.06% 252
2021
Q4 		$1.88M Buy
2,974
+541
+22% +$333K 0.05% 282
2021
Q3 		$1.47M Buy
2,433
+574
+31% +$356K 0.04% 297
2021
Q2 		$1.08M Buy
1,859
+187
+11% +$94.7K 0.04% 312
2021
Q1 		$791K Sell
1,672
-20,688
-93% -$10.1M 0.03% 330
2020
Q4 		$10.8M Buy
22,360
+2,771
+14% +$1.5M 0.48% 47
2020
Q3 		$11.4M Buy
19,589
+1,784
+10% +$1.08M 0.66% 39
2020
Q2 		$11M Buy
17,805
+1,475
+9% +$837K 0.75% 35
2020
Q1 		$8.58M Buy
16,330
+3,771
+30% +$1.56M 0.69% 37
2019
Q4 		$4.72M Buy
12,559
+215
+2% +$72.3K 0.38% 55
2019
Q3 		$4.03M Buy
12,344
+1,457
+13% +$431K 0.33% 62
2019
Q2 		$3.32M Sell
10,887
-269
-2% -$89.6K 0.32% 59
2019
Q1 		$4.58M Buy
11,156
+1,471
+15% +$606K 0.35% 67
2018
Q4 		$4.08M Buy
+9,685
New +$3.54M 0.53% 45

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

TownSquare Capital's REGN Position: Q4 2025 in Review

TownSquare Capital sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 1,345 shares — an estimated $756K sold.

TownSquare Capital first reported a position in REGN in Q4 2018 and held it in 28 quarters. The position peaked at $11.4M in Q3 2020. 1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • TownSquare Capital reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • TownSquare Capital sold 1,345 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $756K.
  • TownSquare Capital first reported a position in Regeneron Pharmaceuticals in Q4 2018 and held it in 28 quarters.
  • TownSquare Capital's Regeneron Pharmaceuticals position peaked at $11.4M in Q3 2020.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on TownSquare Capital's 13F filing for Q4 2025, filed 11 Feb 2026.